Alexis Scherl MD, PhD

Dr. Scherl is a board-certified anatomic pathologist with subspecialty training in gastrointestinal and liver pathology. Since joining Genentech in 2014, Dr. Scherl has supported the GastroImmunology pipeline, including hepatic research programs as well as clinical trials for etrolizumab and IL22-Fc. She has also participated in health authority interactions to enable the definition and implementation of novel histologic clinical trial endpoints for inflammatory bowel disease.

Dr. Scherl completed her MD and Ph.D. degrees through the Medical Scientist Training Program at Albert Einstein College of Medicine, followed by a residency in anatomic pathology at Weill-Cornell Medical Center and an ACGME-certified gastrointestinal/liver pathology fellowship at Yale University School of Medicine.